Corvus Pharmaceuticals In...
(CRVS)
undefined
undefined%
At close: undefined
7.51
2.18%
After-hours Dec 13, 2024, 06:34 PM EST
Balance Sheet (Annual)
Get detailed breakdowns of the balance-sheet with total debts,
total investments, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 |
Cash & Equivalents | 12.62M | 13.16M | 63.46M | 16.45M | 5.15M | 114.60M | 90.06M | 134.90M | 4.11M | 12.52M |
Short-Term Investments | 14.53M | 29.14M | 5.99M | 27.80M | 72.83M | 75.40M | 44.95M | 129.85M | 90.28M | - |
Long-Term Investments | 16.12M | 21.88M | 34.27M | 37.23M | - | - | - | - | - | - |
Other Long-Term Assets | 89.00K | 1.84M | 2.55M | 2.40M | 3.34M | 1.46M | 2.05M | 2.01M | 951.00K | - |
Receivables | 63.00K | 633.00K | 539.00K | 86.00K | 329.00K | 337.00K | 132.00K | 365.00K | 347.00K | - |
Inventory | - | -735.00K | -667.00K | -492.00K | -815.00K | -602.00K | -852.00K | -1.14M | 722.00K | - |
Other Current Assets | 744.00K | 728.00K | 1.32M | 991.00K | 1.03M | 655.00K | 1.05M | 772.00K | 930.00K | 12.00K |
Total Current Assets | 27.96M | 42.30M | 69.45M | 44.26M | 77.98M | 114.60M | 90.06M | 134.90M | 95.66M | 12.53M |
Property-Plant & Equipment | 1.39M | 2.22M | 3.19M | 1.65M | 2.33M | 2.18M | 2.67M | 3.25M | 1.84M | - |
Goodwill & Intangibles | - | - | - | - | - | - | - | - | - | - |
Total Long-Term Assets | 17.60M | 25.94M | 40.00M | 41.27M | 5.66M | 3.63M | 4.72M | 5.25M | 2.80M | - |
Total Assets | 45.55M | 68.24M | 109.45M | 85.53M | 83.65M | 118.23M | 94.78M | 140.15M | 98.46M | 12.53M |
Account Payables | 1.52M | 1.98M | 1.56M | 3.47M | 2.45M | 2.00M | 3.45M | 1.90M | 1.57M | 57.00K |
Deferred Revenue | - | - | 6.96M | - | - | - | - | - | 223.00K | -2.58M |
Short-Term Debt | 2.75M | 1.23M | 1.05M | 1.08M | 878.00K | - | - | - | - | 2.60M |
Other Current Liabilities | 2.60M | 7.55M | 7.08M | 7.60M | 6.90M | 5.03M | 5.51M | 4.04M | 1.27M | 17.00K |
Total Current Liabilities | 6.87M | 12.13M | 12.29M | 13.38M | 12.54M | 7.90M | 9.94M | 7.35M | 3.07M | 2.67M |
Long-Term Debt | - | 2.75M | 5.20M | 2.46M | 4.62M | - | - | - | - | - |
Other Long-Term Liabilities | - | -1.37M | -2.60M | -1.23M | -2.31M | 869.00K | 971.00K | 1.41M | 126.49M | 10.01M |
Total Long-Term Liabilities | - | 1.37M | 2.60M | 1.23M | 2.31M | 869.00K | 971.00K | 1.41M | 126.49M | 10.01M |
Total Liabilities | 6.87M | 12.13M | 12.29M | 13.38M | 12.54M | 7.90M | 9.94M | 7.35M | 129.56M | 12.69M |
Total Debt | 1.37M | 2.60M | 3.65M | 2.31M | 3.19M | - | - | - | - | 2.60M |
Common Stock | 5.00K | 5.00K | 5.00K | 3.00K | 3.00K | 3.00K | 2.00K | 2.00K | - | - |
Retained Earnings | -334.72M | -307.69M | -266.38M | -223.14M | -217.15M | -170.47M | -123.53M | -67.87M | -31.50M | -161.00K |
Comprehensive Income | -967.00K | -563.00K | 1.87M | 4.00K | 29.00K | -34.00K | -41.00K | -39.00K | -45.00K | - |
Shareholders Equity | 38.68M | 56.12M | 97.16M | 72.15M | 71.11M | 110.34M | 84.83M | 132.80M | -31.10M | -159.00K |
Total Investments | 30.65M | 51.02M | 40.26M | 65.03M | 72.83M | 75.40M | 44.95M | 129.85M | 90.28M | - |